|XDATA – February 19th 2016|
|Nico disclosed selling 84% of its $18 million non-brokered equity offering to forty-one investors. The sale started on February 5th according to the document filed at the SEC. Based on the offering’s structure, the company has until February 2017 to raise an extra $2.93 million. The company closed three previous unregistered private placements which raised an estimated $21.68 million.|
|Nico develops technology for the field of corridor surgery, including Cranial, ENT, Spinal and Otolaryngology where access to the surgical site is limited. The company’s technology and products are designed to progress corridor surgery by creating instruments that allow for access through smaller openings and resection of soft tissue abnormalities. Investors include Rose-Hulman Institute of Technology, River Cities Capital Fund, CHV Capital, Cornelius Private Investments, and Twilight Venture Partners.|
|The company is headquartered in Indianapolis IN. Nico elected to keep its revenues undisclosed.
The executive team includes Jeffrey L Hanthorn, Jim Pearson and Joseph L Mark.
The board of directors includes J Carter McNabb, James R Baumgardt, Keith E Brauer and Niles L Noblitt.
The company has raised an estimated total of $36.76 million via private unregistered security offerings.
Status: First close
Industry: Other Health Care
Amount offered: $18 million
Amount placed: $15.07 million
SEC filing: Source
First sale: 02-05-2016
Data as of: 02-19-2016